Marshall Wace’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
190,834
+146,260
+328% +$1.44M ﹤0.01% 1905
2026
Q1
$433K Sell
44,574
-10,204
-19% -$93.5K ﹤0.01% 2505
2025
Q4
$523K Buy
+54,778
New +$558K ﹤0.01% 2220
2023
Q3
– Sell
-10,869
Closed -$742K – 2575
2023
Q2
$742K Buy
+10,869
New +$701K ﹤0.01% 1838
2022
Q4
– Sell
-107,803
Closed -$6.54M – 3320
2022
Q3
$6.54M Sell
107,803
-70,584
-40% -$2.23M 0.01% 1183
2022
Q2
$4.84M Buy
178,387
+167,861
+1,595% +$4.91M 0.01% 1366
2022
Q1
$385K Sell
10,526
-204,165
-95% -$7.36M ﹤0.01% 2891
2021
Q4
$10.6M Buy
214,691
+145,799
+212% +$8.08M 0.02% 830
2021
Q3
$4.91M Buy
+68,892
New +$4.28M 0.02% 949
2021
Q2
– Sell
-23,553
Closed -$591K – 2998
2021
Q1
$591K Sell
23,553
-39,520
-63% -$744K ﹤0.01% 1879
2020
Q4
$758K Buy
+63,073
New +$746K ﹤0.01% 1322
2019
Q3
– Sell
-173,557
Closed -$1.83M – 1884
2019
Q2
$1.83M Buy
+173,557
New +$1.78M 0.02% 790
2018
Q4
– Sell
-14,633
Closed -$191K – 1763
2018
Q3
$191K Buy
+14,633
New +$211K ﹤0.01% 1073
2016
Q2
– Sell
-117,937
Closed -$4.85M – 1126
2016
Q1
$4.85M Buy
+117,937
New +$4.62M 0.05% 351
2015
Q3
– Sell
-222,360
Closed -$11.7M – 1025
2015
Q2
$11.7M Buy
222,360
+204,290
+1,131% +$8.06M 0.15% 154
2015
Q1
$689K Buy
+18,070
New +$464K 0.01% 632
2014
Q4
– Sell
-43,486
Closed -$964K – 928
2014
Q3
$964K Sell
43,486
-8,759
-17% -$186K 0.01% 557
2014
Q2
$1.18M Buy
+52,245
New +$1.31M 0.02% 485

Other funds holding PRTA

Marshall Wace's PRTA Position: Q2 2026 in Review

Marshall Wace increased its Prothena Corp (PRTA) stake by 328% in Q2 2026, buying an estimated $1.44M and bringing the position to 190,834 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Marshall Wace first reported a position in PRTA in Q2 2014 and has held it in 18 quarters since. The position peaked at $11.7M in Q2 2015. 187 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Marshall Wace held 190,834 shares of Prothena Corp worth $1.87M as of Q2 2026.
  • Marshall Wace bought 146,260 Prothena Corp shares in Q2 2026, an estimated $1.44M.
  • Prothena Corp made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1905 holding.
  • Marshall Wace first reported a position in Prothena Corp in Q2 2014 and has held it in 18 quarters since.
  • Marshall Wace's Prothena Corp position peaked at $11.7M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.